Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2026-07-18 @ 7:51 PM
Study NCT ID:
NCT01355068
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2011-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |